The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Trough feel free to increase your short
Just for context this is what Pantheon actually said
antheon Resources plc (AIM: PANR) ("Pantheon" or "the Company"), the oil and gas company with a 100% working interest in the Kodiak and Ahpun projects, collectively spanning 193,000 contiguous acres in close proximity to pipeline and transportation infrastructure on Alaska's North Slope, confirms that it is in discussions with stakeholders about the potential to supply natural gas to consumers in South Central Alaska. There can be no guarantee that these discussions will lead to definitive agreements and the Company's planning basis continues to rely upon reinjection of all hydrocarbons that cannot be exported through the Trans-Alaska Pipeline System ("TAPS") main oil line.
Market hasn't remotely cottoned on to this news lets wait to see what happens if/when an offtake is announced. The volume of shorters posts is accelerating desperation grows this could easily multi bag in my view
It really isn't that difficult Duke say profit
Headline cash consideration of €11.4 million,
From 2021 RNS with initial investment
-- The EUR10 million royalty is a 30-year senior secured financing, with monthly payments commencing immediately in July 2021 on Duke's typical investment terms.
Effectively potential offtake referred to earlier , this could be the key to unlock Pantheon's huge value. Wouldn't want to be short off take would be transformational shorter's closing would force this to multiples of current price. Interesting times in my view
Not surprised to see buys coming in this is a good piece of business for Duke and an ideal way for shareholders to take some cash off the table. This should add significantly to Duke's capital appreciation
Not so sure we are in the dark we have clear visibility of NAV AT 2.5 times the share price. You could argue that share prices of the relevant holdings reflect a risk and reward valuation at this time.
One thing is for sure if Guident and Microsalt achieve what I am expecting they will each be multiples of TEK's current value
Note is interesting to say the least, personally I have a strong view that Microsalt valuation will be far in excess of SP target and is currently circa 77% of their target valuation based on current Microsalt share price
I keep seeing the comments regards CEO/uuninvestable if that is you view no one is stopping you selling at which point you don't need to stop all your time posting on here.
an alternative view might be that TEK have done an incredible job of holding on to over 77% of Microsalt and 100% of Guident.
Valuing TEK at 40% of NAV is an insane discount in my view and very happy to add and hold until value plays out
No they haven't banked any profits on Microsalt at 43p, like some would wish for, they rather hold at 87p sale price adding £14.5m+ plus warrants profit to the underlying value of TEK.
Make as much noise as you like TEK is less than 40% of NAV before we get to Microsalt upside
As for Microsalt is a truly stunning asset buying and holding is the answer in my view
Interesting list of exhibitors:-
https://www.gulfood.com/exhibitors
Https://twitter.com/MicroSaltPLC
We're currently at Gulfood - The World’s Largest, Most Trusted F&B Sourcing Event in Dubai, immersing ourselves in the latest insights and trends shaping the global food industry
At the point where the market values a company at half of NAV share price won't long great for a holders perspective. If you are buying then it is cheap in my view. Microsalt is currently valued at more than the market cap. 10m+ Belluscura shares 5m+ Lucyd shares have a value but Guident and Revive have very significant upside.
All of the above still leaves TEK at 50% of NAV. Over 77% of Microsalt is an stunning asset given the size and scale of the market.
Interesting times ahead for TEK
IMHO
They won't maintain the inheritance tax benefits of AIM if they move to us listening. A lot of very long term shareholders will be ignored if this happens. Mr Hobbs seems to regularly infer that this will end up on the US market very disappointing if they don't maintain dual listing. Imho
Pantheon has very strong momentum at the moment. In my view the shorter's have made a big error with regards the assumption that there will be a large dilutive raise. Any farm in on sensible terms and you wont be able to buy this below 50p. Interesting few weeks ahead as shorts are going to get squeezed IMHO